XTORO
XTORO
Approved
DIN Number
02452928
Drug Class
Human
Market Date
N/A
Company
HC
MerLion Pharmaceuticals GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02452928
AIG Number0157930001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S02AA ANTIINFECTIVES
Product Specifications
Dosage FormSuspension
Route of AdministrationOtic
AHFS Classification52:04.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
FINAFLOXACINActive
Strength: 0.3 % / W/V
Monograph: FINAFLOXACIN